Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Bille

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
The Pediatric Infectious Disease Journal|October 11, 2011
Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levelsVincent Couloigner, Corinne Levy, Martine François, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2022
Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement TherapyMichael Thy, Saïk Urien, Frantz Foissac, et al.
Clinical Pharmacokinetics|October 17, 2022
Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement TherapyMichael Thy, Saik Urien, Naim Bouazza, et al.
Microbiologyopen|August 25, 2022
Discrimination of Escherichia coli, Shigella flexneri, and Shigella sonnei using lipid profiling by MALDI-TOF mass spectrometry paired with machine learningJade Pizzato, Wenhao Tang, Sandrine Bernabeu, et al.
British Journal of Clinical Pharmacology|August 29, 2024
Improving cefazolin exposure in critically ill children using a population pharmacokinetic modelClémence Rivaud, Mehdi Oualha, Elodie Salvador, et al.
Journal of Medical Microbiology|March 18, 2021
Clinical relevance and antimicrobial susceptibility profile of the unknown human pathogen <i>Corynebacterium aurimucosum</i>Charles R Lefèvre, Romain Pelletier, Alban Le Monnier, et al.
European Journal of Clinical Pharmacology|October 27, 2019
Population pharmacokinetics of meropenem in critically ill children with different renal functionsMélanie Rapp, Saïk Urien, Frantz Foissac, et al.
Journal of Clinical Microbiology|December 17, 2020
High-Resolution Typing of <i>Staphylococcus epidermidis</i> Based on Core Genome Multilocus Sequence Typing To Investigate the Hospital Spread of Multidrug-Resistant ClonesAnne Jamet, Julien Guglielmini, Bryan Brancotte, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 23, 2022
Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal functionNoémie de Cacqueray, Déborah Hirt, Yi Zheng, et al.
Clinical Pharmacology and Therapeutics|May 30, 2026
Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome StudyNoémie de Cacqueray, Mehdi Oualha, Frantz Foissac, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
The Pediatric Infectious Disease Journal|October 11, 2011
Pathogens implicated in acute otitis media failures after 7-valent pneumococcal conjugate vaccine implementation in France: distribution, serotypes, and resistance levelsVincent Couloigner, Corinne Levy, Martine François, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2022
Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement TherapyMichael Thy, Saïk Urien, Frantz Foissac, et al.
Clinical Pharmacokinetics|October 17, 2022
Meropenem Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement TherapyMichael Thy, Saik Urien, Naim Bouazza, et al.
Microbiologyopen|August 25, 2022
Discrimination of Escherichia coli, Shigella flexneri, and Shigella sonnei using lipid profiling by MALDI-TOF mass spectrometry paired with machine learningJade Pizzato, Wenhao Tang, Sandrine Bernabeu, et al.
British Journal of Clinical Pharmacology|August 29, 2024
Improving cefazolin exposure in critically ill children using a population pharmacokinetic modelClémence Rivaud, Mehdi Oualha, Elodie Salvador, et al.
Journal of Medical Microbiology|March 18, 2021
Clinical relevance and antimicrobial susceptibility profile of the unknown human pathogen <i>Corynebacterium aurimucosum</i>Charles R Lefèvre, Romain Pelletier, Alban Le Monnier, et al.
European Journal of Clinical Pharmacology|October 27, 2019
Population pharmacokinetics of meropenem in critically ill children with different renal functionsMélanie Rapp, Saïk Urien, Frantz Foissac, et al.
Journal of Clinical Microbiology|December 17, 2020
High-Resolution Typing of <i>Staphylococcus epidermidis</i> Based on Core Genome Multilocus Sequence Typing To Investigate the Hospital Spread of Multidrug-Resistant ClonesAnne Jamet, Julien Guglielmini, Bryan Brancotte, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 23, 2022
Cefepime population pharmacokinetics and dosing regimen optimization in critically ill children with different renal functionNoémie de Cacqueray, Déborah Hirt, Yi Zheng, et al.
Clinical Pharmacology and Therapeutics|May 30, 2026
Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome StudyNoémie de Cacqueray, Mehdi Oualha, Frantz Foissac, et al.
Pageof 7